Skip to content

Electrolysis in Patients With Low Back Pain

Short-term Effectiveness of High- and Low-intensity Percutaneous Electrolysis in Patients With Low Back Pain

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06661070
Acronym
Electrolysis
Enrollment
50
Registered
2024-10-28
Start date
2024-11-04
Completion date
2024-11-23
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low Back, Pain, Multifidus muscle, Trigger Points, shear-wave elastography, pain sensitivity

Brief summary

The goal of this observational study is to investigate the efficacy of percutaneous electrolysis compared with dry needling on pain sensations and multifidus muscle properties in subjects with low back pain. The main questions it aims to answer are: The high-intensity and low-intensity percutaneous electrolysis may induce pressure pain threshold (PPT) changes in myofascial trigger points in the low back during the intervention compared with dry needling. Percutaneous electrolysis interventions may reduce stiffness in the multifidus muscle during the intervention compared with dry needling.

Detailed description

A parallel-group, controlled, triple-blinded, randomized pilot clinical trial comparing the effects of a single session of high-intensity percutaneous electrolysis (HIPE), low-intensity percutaneous electrolysis (LIPE), and dry needling (DN) applied to the multifidus muscle most active MTrP in subjects with low back pain. This clinical trial will follow the Consolidated Standards of Reporting Trials for pragmatic clinical trials. This procedure consists of three trials, i.e., (1, HIPE) 660 uA x 30; (2, LIPE) 220uA x 30; and (3, DN) with 1 twitch response, and the needle inserted 30.

Interventions

EPTE device (Ionclinics, Valencia, Spain)

OTHERDry Needling

A dry needle with size 0.30 × 40 (Agupunt, Barcelona, Spain)

Sponsors

Universidad Complutense de Madrid
CollaboratorOTHER
Universidad Rey Juan Carlos
CollaboratorOTHER
Wroclaw University of Health and Sport Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

A triple-blinded, pilot randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* to report low back pain of at least six months duration, * aged 35 to 50 years, * at least one active trigger point is present in the multifidus muscle.

Exclusion criteria

* pharmacological (e.g., analgesics) or physiotherapy treatment before or during their participation in the study, * needle fear, * prior lower extremity or spine surgery, absence of pain, any musculoskeletal or neuropathic conditions (e.g., peripheral compressive neuropathy, radiculopathy, sarcopenia, fibromyalgia, muscle ruptures), traumatic injuries (e.g., fractures or fissures), or any medical condition or contraindication for needling treatment (e.g., anticoagulants).

Design outcomes

Primary

MeasureTime frameDescription
Pain changes in pain intensity before and after the interventionBaseline, immediately after, and 24 after of interventionA 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patient's current level of shoulder pain, and the worst and lowest level of pain experienced in the preceding week in the shoulder area.

Secondary

MeasureTime frameDescription
Pressure Pain ThresholdBaseline, immediately after, and 24 after of interventionSomedic Algometer type 2 was used to measure PPT. The diameter of the contact tip was 10 mm and covered with 2 mm thick rubber. The pressure on point and its rate was standardized (30 kPa s-1 ). The value of the pain threshold equals the value of the pressure at which the examined person reported that the pressure exerted on a certain point causes pain.
Muscle stiffnessBaseline, immediately after, and 24 after of interventionAn ultrasound machine with shear-wave elastography Canon Aplio A device, using a linear transducer PLT-1005-BT (Canon Medical Corp, 1385 Shimoishigami, Otawara, Tochigi 324-8550, Japan). The console settings will also be standard for all the acquisitions (Frequency=11 MHz, Gain=78 dB, Dynamic Range=75, and Depth=4.5 cm).

Countries

Spain

Contacts

Primary ContactSebastian Klich, PhD, DSc
sebastian.klich@awf.wroc.pl+48713473176

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026